Market Cap

Inventiva SA Market Capitalization:

€214.3 Million

EUR as of Jan. 1, 2024

US$236.7 Million

business Inventiva SA Company Profile

Inventiva SA Main Stock Listing

Euronext: IVA

Market Capitalization History of Inventiva SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Inventiva SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 €214.3 M -10.76%
Jan. 1, 2023 €240.2 M -46.20%
Jan. 1, 2022 €446.4 M -14.04%
Jan. 1, 2021 €519.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Inventiva SA Categories

France languages Healthcare languages Biotechnology
France Healthcare France Biotechnology

Stocks & Indices

Inventiva SA has the following listings and related stock indices.


Stock: Euronext: IVA

Stock: NASDAQ: IVA

Stock: FSX: 6IV

Stock: FSX: 6IVA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.